BioCentury
ARTICLE | Company News

Eisai sales and marketing update

August 18, 2014 7:00 AM UTC

Eisai launched Fycompa perampanel in Belgium as adjunctive treatment of partial onset seizures, with or without secondarily generalized seizures, in epileptics ages 12 years and older - the drug’s ap...